Aytu BioScience (AYTU) Tops Q1 EPS by 21c

Aytu BioScience (NASDAQ: AYTU) reported Q1 EPS of $0.21. Revenue for the quarter came in at $13.9 million.

For earnings history and earnings-related data on Aytu BioScience (AYTU) click here.

You May Also Be Interested In

• Fastenal (FAST) Reports In-Line Q2 EPS, Beats on Revenue
• ADI Global sets revenue and earnings targets ahead of Resideo spin-off
• Wells Fargo (WFC) Tops Q2 EPS by 28c, Beats on Revene